Blood-Based Biomarker Panel for Personalized Lung Cancer Risk Assessment
Last Updated: Friday, July 17, 2026
Investigators found that a combination of a blood-based four-marker protein panel with the prostate lung colorectal ovarian (PLCO)m2012 lung cancer prediction model significantly improved lung cancer risk assessment compared with current US Preventive Services Task Force (USPSTF) criteria.
